Emma P. DeLoughery

The contact activation system as a potential therapeutic target in patients with COVID‐19

Joseph J. Shatzel, Emma P. DeLoughery, Christina U. Lorentz et al. · Research and Practice in Thrombosis and Haemostasis · 2020 · 38 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +17

Red blood cell capacity of modern menstrual products: considerations for assessing heavy menstrual bleeding

Emma P. DeLoughery, Alyssa Covelli Colwill, Alison Edelman et al. · BMJ Sexual & Reproductive Health · 2023 · 34 citations · Full text

Medicine, Gynecology, Hematology +14

There’s something in the water: an overview of jellyfish, their stings, and treatment

Emma P. DeLoughery · International Maritime Health · 2022 · 23 citations · Full text

Life Sciences, Marine Biology, Marine Sciences +13

Retrospective study of rFVIIa, 4‐factor PCC, and a rFVIIa and 3‐factor PCC combination in improving bleeding outcomes in the warfarin and non‐warfarin patient

Emma P. DeLoughery, Brian J. Avery, Thomas G. DeLoughery · American Journal of Hematology · 2016 · 17 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Anticoagulant therapy for women: implications for menstruation, pregnancy, and lactation

Emma P. DeLoughery, Bethany Samuelson Bannow · Hematology · 2022 · 17 citations · Full text

Medicine, Gynecology, Hematology +17